Niigata, Japan

Takafumi Imoto


Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 229(Granted Patents)


Location History:

  • Ibaraki, JP (1997 - 2002)
  • Arai, JP (2002 - 2005)
  • Niigata, JP (2001 - 2006)

Company Filing History:


Years Active: 1997-2006

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Takafumi Imoto: Innovator in Pharmaceutical Compounds

Introduction

Takafumi Imoto is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on the development of innovative compounds that have various medicinal applications.

Latest Patents

Among his latest patents, Imoto has developed imidazole compounds that are useful in treating diseases related to hypoglycemic actions and other therapeutic effects. These compounds are represented by a specific general formula and include salts and pharmaceutical compositions that enhance their efficacy. Additionally, he has patented sulfonamide compounds that demonstrate effectiveness in managing blood sugar levels and possess various pharmacological activities, including smooth muscle relaxation and bronchodilation.

Career Highlights

Throughout his career, Takafumi Imoto has worked with prominent organizations, including Fujisawa Pharmaceutical Company, Ltd. His experience in the pharmaceutical industry has allowed him to contribute to the development of groundbreaking medicinal compounds.

Collaborations

Imoto has collaborated with notable colleagues such as Noritsugu Yamasaki and Takahiro Hiramura. Their combined expertise has further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Takafumi Imoto's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant innovator. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…